A股異動丨天味食品(603317.SH)漲6.45% 獲核准非公開發行不超1億股新股
格隆匯9月15日丨天味食品(603317.SH)漲6.45%,有望實現三連漲,暫報65.89元,總市值396億元。

公司於昨日收到中國證監會《關於核准四川天味食品集團股份有限公司非公開發行股票的批覆》,核准公司非公開發行不超過1億股新股,發生轉增股本等情形導致總股本發生變化的,可相應調整本次發行數量;該批覆自核準發行之日起12個月內有效。
中泰證券研報稱,公司今年推出12款新品、30個單品,涵蓋不辣湯系列、火鍋蘸醬、小龍蝦調料,上半年新品收入佔比提升至8%。預計公司2020-2022年歸母淨利潤分別為3.68、5.33、7.49億元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.